The UK Medicines and Healthcare products Regulatory Agency (MHRA) has made updated safety and educational materials available. These resources are intended to help implement the regulatory measures outlined in the November 2023 National Patient Safety Alert and the September 2024 Drug Safety Update.
The new materials aim to support healthcare professionals in discussing relevant risks with patients, ensuring compliance with the latest safety guidance.
Actualizaciones regulatorias24 ago 2026•1 min de lectura
MHRA Publishes Updated Safety and Educational Materials
MHRA releases new safety and educational resources to support regulatory measures from the 2023 Patient Safety Alert and 2024 Drug Safety Update.
Recopilado por el equipo de PharmaCountry · Fuente: MHRA
Calificaciones
(0)
(0)
(0)
(0)
(0)
Más artículos
Ver todos los artículosInvestigación e Informes
Global Finished Dosage Manufacturing Landscape 2026
5 oct 2026
Actualizaciones regulatoriasKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept 2026
AnálisisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept 2026
Deja tu valoración